Caffeine Clinical Trial
Official title:
Comparison of Methods to Measure the Consumption of Sodium and Caffeine in Children
Verified date | April 2018 |
Source | University of Lausanne Hospitals |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study will compare different methods (24 hour urine collection, evening and morning spots, and questionnaires) to measure the consumption of sodium and cafeine in children and adolescents.
Status | Completed |
Enrollment | 101 |
Est. completion date | February 18, 2018 |
Est. primary completion date | February 18, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 6 Years to 16 Years |
Eligibility |
Inclusion Criteria: - Between 6 and 16 years of age Exclusion Criteria: - A sickness that affects the consumption and excretion of sodium and caffeine (for example, diabetes, cardiovascular or gastrointestinal problems, chronic kidney disease, renal insufficiency) - Taking medication that affects sodium excretion (for example, diuretics) - A intravenous perfusion during the urine collection - Insufficient knowledge of French to understand the instructions |
Country | Name | City | State |
---|---|---|---|
Switzerland | Hôpital du Valais | Sion | Valais |
Lead Sponsor | Collaborator |
---|---|
University of Lausanne Hospitals | Federal Food Safety and Veterinary Office, Hôpital du Valais |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Urinary sodium excretion | Measured in 24 hour urine and estimated from 3 different urinary spots | Over a 2-day period | |
Primary | Urinary caffeine and related metabolites excretion | Measured in 24 hour urine and estimated by a semi-quantitative food frequency questionnaire | Over a 2-day period | |
Secondary | Sodium consumption | Estimated by a semi-quantitative food frequency questionnaire | Over a 2-day period | |
Secondary | Urinary phosphate excretion | Measured in 24 hour urine and estimated from 3 different urinary spots | Over a 2-day period | |
Secondary | Urinary caffeine and metabolites excretion | Measured in 24 hour urine and estimated from 3 different urinary spots | Over a 2-day period | |
Secondary | Urinary albumine excretion | Measured in 24 hour urine and estimated from 3 different urinary spots | Over a 2-day period | |
Secondary | Urinary protein excretion | Measured in 24 hour urine and estimated from 3 different urinary spots | Over a 2-day period |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06038903 -
The Turkish Version Of The Brief-Caffeine Expectancy Questionnaire
|
||
Completed |
NCT03850275 -
The Effects of e+Shots Energy Beverage on Mental Energy
|
N/A | |
Completed |
NCT01924481 -
Effects of a Cocoa Shot on the Human Brain
|
N/A | |
Completed |
NCT01330680 -
Genetic Determinants of Cardiovascular Response to Coffee Drinking
|
N/A | |
Completed |
NCT00184912 -
The Effect of Caffeine on Ischemic Preconditioning
|
N/A | |
Completed |
NCT03859882 -
Protocol PERCAF 2018
|
N/A | |
Completed |
NCT02832401 -
The Impact of Caffeine on Cognition in Schizophrenia
|
N/A | |
Completed |
NCT04560595 -
Remote Guided Caffeine Reduction
|
N/A | |
Recruiting |
NCT05503732 -
Effects of Energy Drinks on Sleep and Cardiovascular Health
|
N/A | |
Not yet recruiting |
NCT05521386 -
The Effects of Caffeine on Heart Rate and Heart Rate Variability
|
N/A | |
Completed |
NCT06039358 -
Effects of Caffeine Ingestion on the Biomechanics of Healthy Young Subjects
|
N/A | |
Active, not recruiting |
NCT04547868 -
Can Coffee/Caffeine Improve Post-Operative Gastrointestinal Recovery
|
N/A | |
Completed |
NCT05559372 -
Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes
|
N/A | |
Completed |
NCT01783561 -
Early Versus Routine Caffeine Administration in Extremely Preterm Neonates
|
Phase 4 | |
Completed |
NCT04852315 -
Acute Caffeine Ingestion on Futsal Performance
|
N/A | |
Completed |
NCT05975489 -
Genetics in the Effect of Caffeine on Fat Oxidation
|
N/A | |
Recruiting |
NCT03298347 -
Caffeine for Preterm Infants With Apnea of Prematurity(AOP)
|
N/A | |
Completed |
NCT01435486 -
Caffeine Citrate for the Treatment of Apnea Associated With Bronchiolitis in Young Infants
|
N/A | |
Completed |
NCT04869176 -
Effect of Caffeine on Heart Rate Variability in Newborns
|
N/A | |
Completed |
NCT04585854 -
Effect of Caffeine on Myocardial Oxygenation
|
N/A |